Cabaletta Bio (NASDAQ:CABA) used a fireside chat at TD Cowen’s 46th Annual Health Care Conference to highlight progress ...

Systemic sclerosis (SSc), also known as scleroderma, is a complex connective tissue disease that is associated with a high mortality and is challenging to treat because of its clinical heterogeneity ...

CEO Sanjay Shukla outlined the company’s strategy to develop new therapies for inflammation and fibrosis based on tRNA synthetase biology during a presentation at the Leerink Partners Global ...

Artificial intelligence is emerging as a powerful tool for improving the diagnosis, phenotyping, and treatment of inflammatory skin diseases such as alopecia.

Detailed price information for Quoin Pharmaceuticals Ltd ADR (QNRX-Q) from The Globe and Mail including charting and trades.

Clearway Testing has partnered with clinics in Wichita to provide testing for those who have lived, worked, or attended church or schools in the area from the 1970s up to the present day.

Fast Track Designation facilitates development and expedites regulatory review of therapies addressing serious conditions ...

Pawn Stars” personality Corey Harrison and his friend have asked for financial help from fans after Harrison suffered serious injuries in a motorcycle crash in Mexico. Harrison, known to fans as “Big ...

BullshitBench tests whether AI models can detect nonsensical questions—or if they'll confidently answer them anyway. The ...

Initial $50M Series A investment from founding investor RTW InvestmentsProceeds will fund clinical development of PRO-203 in systemic sclerosis ...

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2025 Earnings Call Transcript March 12, 2026 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.22551.

After 20 years, the owners of Story’s Clothing are closing the doors on their business owing to family health reasons. The store on Ruataniwha St will close at the end of March, with owner Gerard ...